SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin
PLOS One · 2025
DOI: 10.1371/journal.pone.0336015 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Hye-Kyung Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Brain Diseases Research, Department of Chronic Disease Convergence Research, Korea National Institute of Health, Cheongju-si, Republic of…. Hauptthemen laut MEDLINE: Metformin, alpha-Synuclein, Cognitive Dysfunction, tau Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea National Institute of Health.
Abstract (Originalsprache)
Patients recovering from post-coronavirus disease 2019 (COVID-19) often experience cognitive dysfunction, including difficulties with focusing, conversation, or memory issues, which can persist for weeks or even months after infection. Although the persistence of the SARS-CoV-2 spike protein has been reported in both the brain and serum, and is thought to potentially contribute to the long-term effects of SARS-CoV-2 infection on the brain, the underlying mechanisms leading to cognitive dysfunction remain unclear. This study investigates the molecular mechanisms by which the SARS-CoV-2 S1 protein (hereafter S1) induces cognitive impairment and explores the therapeutic potential of metformin in mitigating these effects. We demonstrate that intranasally administered S1 quickly entered the hippocampus and was associated with cognitive impairment by 6 weeks post-injection. Transcriptomic analysis of hippocampal tissue revealed early alterations in gene expression associated with synaptic function. We observed that the expression of hypoxia-responsive genes was also altered, suggesting the involvement of HIF-1α signaling. Further analysis confirmed that S1 stabilized the HIF-1α protein in a hypoxia-independent manner, and siRNA-mediated knockdown of HIF-1α restored synaptic gene expression, including GRIN2A, SHANK1, and JPH3. By 6 weeks post-injection, hippocampal neuronal loss was accompanied by the accumulation of phosphorylated tau (p-tau) and aggregated α-synuclein. Notably, treatment with metformin rescued synaptic gene expression and attenuated p-tau and α-synuclein aggregation. These findings suggest that S1 disrupts synaptic homeostasis and promotes neurodegenerative processes, and that metformin may serve as a potential therapeutic strategy to mitigate long-term cognitive sequelae of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Brain Diseases Research, Department of Chronic Disease Convergence Research, Korea National Institute of Health, Cheongju-si, Republic of Korea.
- Nexmos Inc., Yongin-si, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Hye-Kyung Lee, Young Ho Koh
Förderung
- Korea National Institute of Health
Zitieren
APA
Lee, H. K., Choi, J. Y., Park, J. H., Chang, M. H., Park, J. H., & Koh, Y. H. (2025). SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin. PLOS One. https://doi.org/10.1371/journal.pone.0336015
Vancouver
Lee HK, Choi JY, Park JH, Chang MH, Park JH, Koh YH. SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin. PLOS One. 2025. doi:10.1371/journal.pone.0336015
BibTeX
@article{Lee2025,
author = {Lee, Hye-Kyung and Choi, Ji Young and Park, Jung Hyun and Chang, Moon Han and Park, Jung Ho and Koh, Young Ho},
title = {SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336015}
}
EUVIMED